TrialJournal of hematology & oncology2014

Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG).

Yong-Rong Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.